A Look At The Ugly Reality About ADHD Medication Pregnancy > 자유게시판

intuniv adhd medication Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how long-term exposure may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to weigh the benefits of taking it against the possible risks for the foetus. Physicians do not have the information needed to give clear guidelines, but they can provide information regarding risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at greater risk of fetal malformations or structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was accurate and to minimize any bias.

The study conducted by the researchers had some limitations. In particular, they were not able to differentiate the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult to know whether the small associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. The researchers did not look at long-term outcomes for offspring.

The study revealed that infants whose mother took ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.

The researchers suggest that the small risk associated with the use of strongest adhd medication medications during the early stages of pregnancy may be offset by the greater benefit to both the mother and child of continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, when possible, help them develop strategies for improving their coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Interactions with Medication

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, physicians must take into account their own experience, the experience of other doctors, and the research that has been conducted on the subject.

The issue of potential risks to infants is extremely difficult. The research on this subject is based on observations rather than controlled studies and a lot of the results are conflicting. Most studies focus on live births, which may underestimate the teratogenic impact leading to abortions or terminations of pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion Some studies have revealed an association between ADHD medications and certain birth defects, other studies have not established a link. Most studies show a neutral, or even slightly negative, impact. In all cases, a careful study of the risks and benefits is required.

For a lot of women with ADHD who suffer from ADHD, the decision to stop taking medication is difficult, if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. The loss of medication can affect the ability to drive safely and to perform work-related tasks which are essential aspects of daily life for those with ADHD.

She suggests women who are uncertain about whether to continue or stop taking medication because of their pregnancy should consider informing family members, friends and colleagues on the condition, its impact on daily functioning, and on the benefits of keeping the current treatment regimen. In addition, educating them can aid in ensuring that the woman feels supported when she is struggling with her decision. It is important to note that some medications are able to be absorbed through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be passed on to the baby.

Risk of Birth Defects

As the use and misuse of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (safest adhd medication for adults) is increasing, so does concern about the potential adverse effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Using two massive data sets researchers were able analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study didn't find any association between early use of medication and other congenital anomalies like facial deformities, or club feet. The findings are in line with previous studies revealing an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, when a lot of women begin to discontinue their ADHD medications.

Women who took get adhd Medication online medication during the first trimester were more likely to require a caesarean birth, have an insufficient Apgar after delivery, and have a baby who needed help breathing after birth. The authors of the study could not remove bias in selection since they limited their study to women with no other medical conditions that might have contributed to the findings.

Researchers hope that their research will help doctors when they meet pregnant women. The researchers recommend that, while discussing the risks and benefits are important, the decision about whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that, while stopping the medication is an option, it isn't a recommended practice because of the high rate of depression and other mental health problems for women who are expecting or recently post-partum. Research has also shown that women who stop taking their medication will have a harder time adjusting to a life without them after the baby is born.

Nursing

It can be overwhelming to become a mom. Women with ADHD can face severe challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to a new routine. As such, many women decide to continue taking their ADHD medication throughout the pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medications is absorbed through breast milk in low amounts. The amount of exposure to medications will vary based on the dosage, frequency of administration and time of day. In addition, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't yet fully understood.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the benefits of taking her medication as well as the risks to the embryo. Until more information becomes available, doctors may inquire about pregnant patients if they have a history of ADHD or if they plan to take medication during the perinatal stage.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner during pregnancy and breast-feeding. In response, a growing number of patients are choosing to continue their medication. They have concluded after consulting with their physicians, that the benefits of retaining their current medication far outweigh any risk.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD understand their symptoms and underlying disorder, learn about available treatments and to reinforce existing strategies for managing. This should be a multidisciplinary process with the GPs, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.